If a drug prevents reuptake of neurotransmitters at inhibitory synapses in the spinal cord, which consequence follows?

💡 Explanation

Blocking reuptake prolongs neurotransmitter presence in the synaptic cleft, therefore enhancing the inhibitory postsynaptic potentials because the neurotransmitter continues to bind to receptors. This effect is potentiation, rather than reducing firing through other mechanisms or affecting synthesis.

• Why does collagen degradation in articular cartilage accelerate osteoarthritis progression as individuals age?
• Which risk increases as Factor XII levels rise excessively in the blood?
• Why does escalating nicotine intake lead to reduced reward despite increased dopamine release in smokers?
• Why does chronic intense musculoskeletal pain from nerve damage persist despite taking NSAIDs?
• Why does aspirin reduce inflammation-induced fever, rather than directly lowering a fever due to strenuous exercise?
• A patient with chronic kidney disease develops osteomalacia. Which mechanism explains why impaired kidney function affects bone mineralization?